ClassID:

94097

C07D209/12 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring Radicals substituted by oxygen atoms

Recent Application in this class:
#1
20260132108
2026-05-14

PREPARATION OF MESEMBRINE

#2
20260125348
2026-05-07

ARYL HYDROCARBON RECEPTOR ACTIVATORS

#3
20260125340
2026-05-07

METHOD FOR PREPARING AMIDES FROM ESTERS

#4
20260092045
2026-04-02

SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS

#5
20260049055
2026-02-19

SOLID FORMS OF MESEMBRINE AND THERAPEUTIC USES THEREOF

#6
20260034119
2026-02-05

5-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS

#7
20260028482
2026-01-29

Substitution at the Central Position of Heptamethine Dyes By Aryllithium Addition for Improved Fluorophores

#8
20260015322
2026-01-15

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#9
20250382276
2025-12-18

COMPOUND, METHOD OF PREPARATION, COMPOSITION, AND USES THEREOF

#10
20250382269
2025-12-18

METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES

#11
20250382268
2025-12-18

METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES

#12
20250346559
2025-11-13

COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION, KIT AND USE THEREOF

#13
20250320186
2025-10-16

HSD17B13 INHIBITORS AND USES THEREOF

#14
20250243161
2025-07-31

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#15
20250229262
2025-07-17

CHIRAL SPIROCYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF

#16
20250154099
2025-05-15

PREPARATION METHOD OF 2-PHENYLINDOLE DERIVATIVES AND APPLICATION THEREOF

#17
20250091992
2025-03-20

NOVEL COMPOUNDS AND USES THEREOF

#18
20250059156
2025-02-20

THERAPEUTIC ALKALOID COMPOUNDS

#19
20250051277
2025-02-13

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#20
20250034139
2025-01-30

AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY

#21
20250026718
2025-01-23

SOLID FORMS OF MESEMBRINE AND THERAPEUTIC USES THEREOF

#22
20250011281
2025-01-09

THERAPEUTIC ALKALOID COMPOUNDS

#23
20240409566
2024-12-12

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#24
20240409512
2024-12-12

NOVEL CRYSTALLINE SALT FORMS OF MESEMBRINE

#25
20240408119
2024-12-12

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#26
20240400508
2024-12-05

ALKYL-SUBSTITUTED DERIVATIVES OF MESEMBRINE AND MESEMBRENONE AND THERAPEUTIC USES THEREOF

#27
20240376052
2024-11-14

N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#28
20240327556
2024-10-03

COMPOUND, POLYMERIZABLE COMPOSITION, OPTICALLY ANISOTROPIC FILM, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE

#29
20240327419
2024-10-03

SYNTHESIS OF SUBSTITUTED TRICYCLIC AMIDES AND ANALOGUES THEREOF

#30
20240308959
2024-09-19

PROCESSES FOR THE PREPARATION OF (S)-2-(4-CHLORO-2-METHOXYPHENYL)-2-((3 -METHOXY-5-(M ETHYLSULFONYL)PHENYL)AMINO)-1 -(1H-INDOL-3-YL)ETHENONE DERIVATIVES

#31
20240294494
2024-09-05

SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS

#32
20240279550
2024-08-22

REACTIVE MESOGENS

#33
20240270713
2024-08-15

NOVEL COMPOUND EXHIBITING THERAPEUTIC EFFECT ON INFLAMMATORY DISEASE AS P38 MAP KINASE INHIBITOR

#34
20240254080
2024-08-01

MALASSEZIN AND ANALOGS THEREOF AS SKIN BRIGHTENING AGENTS

#35
20240246910
2024-07-25

Delivery of therapeutic alkaloid compounds

#36
20240199543
2024-06-20

Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same

#37
20240174606
2024-05-30

INDOLE COMPOUNDS, AND PREPARATION METHODS, AND USES THEREOF

#38
20240132450
2024-04-25

MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88

#39
20240116923
2024-04-11

USE OF INDOLE, 6- AND 7-AZAINDOLE DERIVATIVES AS INHIBITORS OF FERROPTOSIS REGULATED CELL DEATH

#40
20240116870
2024-04-11

N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF

#41
20240101513
2024-03-28

Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same

#42
20240076263
2024-03-07

METHOD FOR PREPARING CHIRAL NITRO DERIVATIVES USING ORGANIC CHIRAL CATALYST COMPOUNDS AND ECO-FRIENDLY SOLVENTS

#43
20240067652
2024-02-29

METHOD OF PREPARING INDOLINOBENZODIAZEPINE DERIVATIVES

#44
20240023549
2024-01-25

FUNGICIDAL ARYL AMIDINES

#45
20230357146
2023-11-09

Prodrugs and conjugates of dimethyltryptamine

#46
20230348405
2023-11-02

PSMA-TARGETING COMPOUNDS AND USES THEREOF

#47
20230348380
2023-11-02

Aza-substituted psilocin analogs and methods of synthesizing the same

#48
20230320564
2023-10-12

CA IX - NIR DYES AND THEIR USES

#49
20230312469
2023-10-05

Crystalline salt forms of mesembrine

#50
20230302160
2023-09-28

TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING

#51
20230271924
2023-08-31

Novel Psilocin Analog Compositions And Methods of Synthesizing The Same

#52
20230242557
2023-08-03

Proteasome activity enhancing compounds

#53
20230227406
2023-07-20

MODULATORS OF E3 LIGASES

#54
20230218578
2023-07-13

BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF

#55
20230212119
2023-07-06

N,N-dimethyltryptamine and related psychedelics and uses thereof

#56
20230159455
2023-05-25

Delivery of therapeutic alkaloid compounds

#57
20230145074
2023-05-11

Indole compounds and their use

#58
20230122909
2023-04-20

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE

#59
20230099716
2023-03-30

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

#60
20230072867
2023-03-09

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

#61
20230066720
2023-03-02

Prodrugs and conjugates of dimethyltryptamine

#62
20230041584
2023-02-09

NOVEL PRODRUGS AND CONJUGATES OF DIMETHYLTRYPTAMINE

#63
20230016922
2023-01-19

VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES

#64
20230014907
2023-01-19

INHIBITORS OF APOL1 AND METHODS OF USING SAME

#65
20220402869
2022-12-22

TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF

#66
20220356166
2022-11-10

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

#67
20220356139
2022-11-10

SYNTHESIS OF DEUTERATED ALDEHYDES

#68
20220324806
2022-10-13

Cannabinoid derivatives

#69
20220298181
2022-09-22

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

#70
20220281824
2022-09-08

ARYL HYDROCARBON RECEPTOR ACTIVATORS

#71
20220259161
2022-08-18

PSMA-targeting compounds and uses thereof

#72
20220185828
2022-06-16

Silylated derivatives of aromatic heterocycles

#73
20220110962
2022-04-14

ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF

#74
20220106270
2022-04-07

Enhancer of fertilization function of sperm

#75
20220048872
2022-02-17

PSMA targeted fluorescent agents for image guided surgery

#76
20210380532
2021-12-09

and analogs thereof as skin brightening agents

#77
20210371576
2021-12-02

INDOLE-BASED COMPOUNDS

#78
20210355084
2021-11-18

N-SUBSTITUTED INDOLES AND USE AS ALLOSTERIC MODULATORS OF CANNABINOID RECEPTORS

#79
20210292329
2021-09-23

Process for preparing substituted indolines

#80
20210269397
2021-09-02

5-aminolevulinate synthase inhibitors and methods of use thereof

#81
20210260035
2021-08-26

Indole compounds and analogues thereof

#82
20210238158
2021-08-05

PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS

#83
20210221786
2021-07-22

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

#84
20210214359
2021-07-15

Compounds and Methods for Treating Bacterial Infections

#85
20210179604
2021-06-17

Indole compounds and their use

#86
20210179556
2021-06-17

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

#87
20210163476
2021-06-03

Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#88
20210130320
2021-05-06

Antiestrogen compounds

#89
20210122733
2021-04-29

Amino compounds for treatment of immune and inflammatory disorders

#90
20210122710
2021-04-29

Phenylamine compounds

#91
20210087174
2021-03-25

Aryl and heteroaryl substituted indole compounds

#92
20210070751
2021-03-11

Substituted indole ether compounds

#93
20210063406
2021-03-04

CA IX-NIR dyes and their uses

#94
20210047348
2021-02-18

Silylated derivatives of aromatic heterocycles

#95
20200360542
2020-11-19

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

#96
20200354353
2020-11-12

Indole compounds and their use

#97
20200339581
2020-10-29

Amino indole compounds useful as TLR inhibitors

#98
20200308198
2020-10-01

Proteasome activity enhancing compounds

#99
20200231559
2020-07-23

Hydrophilic compounds for optically active devices

#100
20200216402
2020-07-09

PSMA targeted fluorescent agents for image guided surgery

#101
20200190066
2020-06-18

Compound used as autophagy regulator, and preparation method therefor and uses thereof

#102
20200174009
2020-06-04

CA IX—NIR dyes and their uses

#103
20200115396
2020-04-16

Silylated derivatives of aromatic heterocycles

#104
20200109145
2020-04-09

Methods of preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indoles

#105
20200109124
2020-04-09

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#106
20200062790
2020-02-27

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#107
20200030290
2020-01-30

INDAZOLE AND INDOLE DERIVATIVES AS INHIBITORS OF RETINOIC ACID RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA) FOR THE TREATMENT OF IMMUNE-RELATED DISEASES

#108
20190389827
2019-12-26

Compounds for optically active devices

#109
20190367475
2019-12-05

PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention

#110
20190345135
2019-11-14

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

#111
20190330201
2019-10-31

Aryl hydrocarbon receptor modulators

#112
20190292149
2019-09-26

ARYL SUBSTITUTED INDOLES AND THE USE THEREOF

#113
20190284149
2019-09-19

ARYL HYDROCARBON RECEPTOR MODULATOR

#114
20190284136
2019-09-19

INDOLINE DERIVATIVES

#115
20190284135
2019-09-19

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

#116
20190276467
2019-09-12

Substituted indole compound derivatives as dengue viral replication inhibitors

#117
20190274999
2019-09-12

Substituted indole derivatives as dengue viral replication inhibitors

#118
20190248836
2019-08-15

DNA primase and gyrase inhibitors

#119
20190248805
2019-08-15

Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

#120
20190225811
2019-07-25

Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

#121
20190225596
2019-07-25

Cannabinergic nitrate esters and related analogs

#122
20190210991
2019-07-11

PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS

#123
20190194193
2019-06-27

Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#124
20190185498
2019-06-20

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#125
20190144473
2019-05-16

Amino compounds for treatment of complement mediated disorders

#126
20190144450
2019-05-16

Modulators of ATP-binding cassette transporters

#127
20190142802
2019-05-16

Benzopyrazole compounds and analogues thereof

#128
20190127337
2019-05-02

Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute

#129
20190112276
2019-04-18

PU.1 inhibitors

#130
20190092749
2019-03-28

EPAC1 activators as HIV latency reversal agents (LRA)

#131
20190085005
2019-03-21

Phosphonate compounds for treatment of complement mediated disorders

#132
20190084922
2019-03-21

Quaternized ammonium salts of hydrocarbyl epoxides and use thereof as additives in fuels and lubricants

#133
20190048033
2019-02-14

Ether compounds for treatment of complement mediated disorders

#134
20190048030
2019-02-14

Silylated derivatives of aromatic heterocycles

#135
20190031692
2019-01-31

Compounds for treatment of complement mediated disorders

#136
20190023729
2019-01-24

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#137
20180370913
2018-12-27

Malassezin and analogs thereof as skin brightening agents

#138
20180346486
2018-12-06

Heterocyclic compounds

#139
20180339989
2018-11-29

Methods for preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-6-ones

#140
20180312493
2018-11-01

Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses Therefor

#141
20180298043
2018-10-18

Alkyne Compounds for Treatment of Complement Mediated Disorders

#142
20180298000
2018-10-18

AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY

#143
20180297996
2018-10-18

Non-selective protease activated receptor 4 ALA120THR isoform antagonist

#144
20180291047
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#145
20180291046
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#146
20180282352
2018-10-04

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

#147
20180273758
2018-09-27

Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

#148
20180271098
2018-09-27

Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents

#149
20180258098
2018-09-13

Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

#150
20180256545
2018-09-13

Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

#151
20180256544
2018-09-13

Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

#152
20180244643
2018-08-30

HIGHLY SENSITIVE DETECTION OF BIOMOLECULES USING PROXIMITY INDUCED BIOORTHOGONAL REACTIONS

#153
20180222916
2018-08-09

Functionalized NANOLUC inhibitors

#154
20180222861
2018-08-09

Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them

#155
20180208583
2018-07-26

Oxime ester photoinitiators

#156
20180201580
2018-07-19

Compounds for treatment of immune inflammatory disorders

#157
20180194750
2018-07-12

Indole compounds having antiprotozoal activity and its use as well as methods for producing the same

#158
20180179185
2018-06-28

Amino compounds for treatment of immune and inflammatory disorders

#159
20180162807
2018-06-14

Aromatic compounds and uses thereof

#160
20180118681
2018-05-03

Cannabinoid type 1 receptor modulators

#161
20180086701
2018-03-29

Enantioselective synthesis of pyrroloindole compounds

#162
20180078520
2018-03-22

Compositions for prevention/prophylactic treatment of poison ivy dermatitis

#163
20180057514
2018-03-01

Preparation of silylamines by the dehydrogeative coupling of N—H and Si—H bonds

#164
20180029990
2018-02-01

Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection

#165
20180022699
2018-01-25

Aryl substituted indoles and the use thereof

#166
20180009767
2018-01-11

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#167
20180002305
2018-01-04

PROCESS FOR PREPARING BENZOFURAN-2-CARBOXAMIDE DERIVATIVES

#168
20170369783
2017-12-28

Polymerizable compound and optically anisotropic object

#169
20170349752
2017-12-07

Yellow methine dyes

#170
20170349546
2017-12-07

Light-Activated Two-Component Protein Binding Matrix

#171
20170342047
2017-11-30

Cancerous cell growth inhibiting compounds

#172
20170333576
2017-11-23

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

#173
20170320824
2017-11-09

MAP4K4 (HGK) inhibitors

#174
20170305915
2017-10-26

Indazole and indole derivatives as inhibitors of retinoic acid related orphan receptor gamma (ROR gamma) for the treatment of immune-related diseases

#175
20170298085
2017-10-19

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#176
20170298084
2017-10-19

Amide compounds for treatment of complement mediated disorders

#177
20170291881
2017-10-12

Efficient and scalable synthesis of 2-(1′h-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs

#178
20170283384
2017-10-05

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#179
20170267655
2017-09-21

Process for preparing benzofuran-2-carboxamide derivatives

#180
20170260133
2017-09-14

and analogs thereof as skin brightening agents

#181
20170253580
2017-09-07

[3+2] annulation to produce 5-membered heterocyclic compounds

#182
20170240521
2017-08-24

PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN

#183
20170226142
2017-08-10

Factor D Inhibitors Useful for Treating Inflammatory Disorders

#184
20170224658
2017-08-10

Mono- or di-substituted indoles as dengue viral replication inhibitors

#185
20170210728
2017-07-27

Cannabinergic nitrate esters and related analogs

#186
20170189410
2017-07-06

Amino compounds for treatment of complement mediated disorders

#187
20170174624
2017-06-22

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

#188
20170129879
2017-05-11

4-substituted-2-(5-substituted-1H-indol-2-yl)phenol derivatives, methods for preparing the phenol derivatives and pharmaceutical compositions for inhibiting cell proliferation and migration including the phenol derivatives

#189
20170096393
2017-04-06

Bis-indolylmethanes, a process for their preparation and uses thereof

#190
20170088516
2017-03-30

α-glucosidase inhibitors

#191
20170057993
2017-03-02

Ether compounds for treatment of medical disorders

#192
20170050928
2017-02-23

Indolyl-containing RORγt inhibitors

#193
20170022195
2017-01-26

Aryl and heteroaryl ether compounds as ROR gamma modulators

#194
20170020840
2017-01-26

Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors

#195
20170008843
2017-01-12

Monomer, organic layer composition, organic layer, and method of forming patterns

#196
20170008842
2017-01-12

Method for producing indoline compound

#197
20170008820
2017-01-12

Method for producing optically active carboxylic acid ester

#198
20160376260
2016-12-29

Slow release of organoboronic acids in cross-coupling reactions

#199
20160362417
2016-12-15

Process for the preparation of 5-fluorotryptophol

#200
20160355474
2016-12-08

3,3′-disubstituted indolines as inhibitors of cholesterol ester transfer protein

#201
20160333031
2016-11-17

Proteasome activity enhancing compounds

#202
20160326163
2016-11-10

Bicyclic heteroaryl indole analogues useful as ROR gamma modulators

#203
20160326111
2016-11-10

ARYL SUBSTITUTED INDOLES AND THE USE THEREOF

#204
20160280650
2016-09-29

NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS

#205
20160280626
2016-09-29

Antidiabetic bicyclic compounds

#206
20160272577
2016-09-22

ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

#207
20160264523
2016-09-15

CONJUGATE COMPRISING FOLIC ACID AND INDOLE-3-CARBINOL FOR MEDICAL USE

#208
20160263566
2016-09-15

Phosphine ligands for catalytic reactions

#209
20160257701
2016-09-08

Heterocyclic compounds

#210
20160251343
2016-09-01

Photoacid compositions having extended lifetime of proton dissociation state

#211
20160251339
2016-09-01

Aromatic heterocyclic compounds and their application in pharmaceuticals

#212
20160237083
2016-08-18

Indoles as respiratory syncytial virus antiviral agents

#213
20160229840
2016-08-11

Activatable fluorogenic compounds and uses thereof as near infrared probes

#214
20160214966
2016-07-28

Oxime ester photoinitiators

#215
20160214951
2016-07-28

EBI2 modulators

#216
20160200744
2016-07-14

Convenient process for the preparation of statins

#217
20160200709
2016-07-14

Indole compound as inhibitor of necrosis

#218
20160199348
2016-07-14

Compounds

#219
20160194281
2016-07-07

CRYSTALLINE FORMS OF SILODOSIN

#220
20160176875
2016-06-23

Spirocyclic EBI2 modulators

#221
20160176819
2016-06-23

ASYMMETRICALLY CHARGED NIR FLUOROPHORES

#222
20160176818
2016-06-23

Method for preparing silodosin

#223
20160176772
2016-06-23

Silylation of aromatic heterocycles by disilanes using potassium alkoxide catalysts

#224
20160159740
2016-06-09

Indole 3-carbinol derivatives

#225
20160122362
2016-05-05

Inhibitors of equilibrative nucleoside transporter type I as anti-parasitic compounds

#226
20160083409
2016-03-24

METHOD FOR THE PREPARATION OF alpha-SUBSTITUTED ACRYL ALDEHYDES

#227
20160046653
2016-02-18

Silylation of aromatic heterocycles by earth abundant transition-metal-free catalysts

#228
20160031812
2016-02-04

Sepiapterin reductase inhibitors for the treatment of pain

#229
20160024058
2016-01-28

Process for preparing benzofuran-2-carboxamide derivatives

#230
20160024008
2016-01-28

Process for preparing benzofuran-2-carboxamide derivatives

#231
20160016931
2016-01-21

Compounds for treating inflammatory and hyperproliferative diseases

#232
20160002224
2016-01-07

Indole derivatives useful as anti-diabetic agents

#233
20160002195
2016-01-07

Cannabinergic nitrate esters and related analogs

#234
20150361077
2015-12-17

Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#235
20150361045
2015-12-17

Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection

#236
20150360215
2015-12-17

Phosphine ligands for catalytic reactions

#237
20150336889
2015-11-26

INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS DNA METHYLATION MODULATORS

#238
20150322030
2015-11-12

Process for preparing benzofuran-2-carboxamide derivatives

#239
20150315186
2015-11-05

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#240
20150315143
2015-11-05

N-heterocyclic carbene-catalyzed synthesis of 2-aryl indoles

#241
20150299189
2015-10-22

Amine derivative or salt thereof

#242
20150299119
2015-10-22

Indole derivatives as inhibitors of histone deacetylase

#243
20150291699
2015-10-15

Pictet-Spengler ligation for protein chemical modification

#244
20150291584
2015-10-15

GPR40 receptor agonist, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent

#245
20150266892
2015-09-24

AMPK Modulators

#246
20150266820
2015-09-24

Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases

#247
20150266808
2015-09-24

Quaternized ammonium salts of hydrocarbyl epoxides and use thereof as additives in fuels and lubricants

#248
20150263296
2015-09-17

Organic electroluminescent device

#249
20150252043
2015-09-10

Hematopoietic growth factor mimetic small molecule compounds and their uses

#250
20150250793
2015-09-10

BAX agonist, compositions, and methods related thereto

#251
20150246905
2015-09-03

Slow release of organoboronic acids in cross-coupling reactions

#252
20150239859
2015-08-27

Peripherally-acting cannabinoid receptor agonists for chronic pain

#253
20150239796
2015-08-27

ONE POT SYNTHESIS OF 18F LABELEDTRIFLUOROMETHYLATED COMPOUNDS WITH DIFLUORO(IODO)METHANE

#254
20150225335
2015-08-13

Hydroxamic acid derivative

#255
20150218632
2015-08-06

System and methods for nucleic acid sequencing of single molecules by polymerase synthesis

#256
20150218380
2015-08-06

Modified carbocyanine dyes and their conjugates

#257
20150218133
2015-08-06

6-aminoindole derivatives as TRP channel antagonists

#258
20150218122
2015-08-06

Process of producing cycloalkylcarboxamido-indole compounds

#259
20150203490
2015-07-23

Ring-fused compound

#260
20150202176
2015-07-23

Compositions for prevention/prophylactic treatment of poison ivy dermatitis

#261
20150183744
2015-07-02

Activators of human pyruvate kinase

#262
20150166543
2015-06-18

Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation

#263
20150164905
2015-06-18

Compounds and methods for inhibiting phosphate transport

#264
20150164861
2015-06-18

Autotaxin inhibitors and uses thereof

#265
20150157741
2015-06-11

Compound and photoacoustic imaging contrast medium containing the compound

#266
20150152126
2015-06-04

Phosphine ligands for catalytic reactions

#267
20150152049
2015-06-04

Materials and methods useful to induce vacuolization, cell death, or a combination thereof

#268
20150104387
2015-04-16

PSMA-targeting compounds and uses thereof

#269
20150099781
2015-04-09

Compounds and methods for treating mammalian gastrointestinal microbial infections

#270
20150099720
2015-04-09

Androgen receptor modulator compounds and methods

#271
20150094330
2015-04-02

Compounds and methods for skin repair

#272
20150087617
2015-03-26

Indole, indoline derivatives, compositions comprising them and uses thereof

#273
20150065487
2015-03-05

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#274
20150045562
2015-02-12

Chemical process for preparing spiroindolones and intermediates thereof

#275
20150038727
2015-02-05

METHOD FOR PREPARING SILODOSIN

#276
20150038542
2015-02-05

USES OF SELECTIVE INHIBITORS OF HDAC8 AND TREATMENT OF INFLAMMATORY CONDITIONS

#277
20150031738
2015-01-29

Cyclic compounds and methods of making and using the same

#278
20150031722
2015-01-29

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#279
20150005494
2015-01-01

Processes for preparing indoles

#280
20140371454
2014-12-18

Catalysts for efficient Z-selective metathesis

#281
20140364477
2014-12-11

Indolyl or indolinyl hydroxamate compounds

#282
20140357634
2014-12-04

Substituted 4-aminocyclohexane derivatives

#283
20140350268
2014-11-27

Chiral imidodiphosphates and derivatives thereof

#284
20140343315
2014-11-20

Modulators of ATP-binding cassette transporters

#285
20140343114
2014-11-20

Potent poxvirus inhibitor

#286
20140323535
2014-10-30

5-oxo-ETE receptor antagonist compounds

#287
20140323475
2014-10-30

EP1 receptor ligands

#288
20140322128
2014-10-30

Materials and methods useful to induce cell death via methuosis

#289
20140315965
2014-10-23

Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer

#290
20140315956
2014-10-23

SMALL MOLECULE INHIBITORS OF IL-6 AND USES THEREOF

#291
20140311890
2014-10-23

PHOTOACID COMPOUNDS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

#292
20140309264
2014-10-16

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

#293
20140308208
2014-10-16

Caged compound delivery and related compositions, methods and systems

#294
20140295437
2014-10-02

Cyanine compounds and their application as quenching compounds

#295
20140294962
2014-10-02

Method of preparing polymorphic pure form A of bazedoxifene acetate

#296
20140275108
2014-09-18

NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS

#297
20140249197
2014-09-04

Indole derivatives as selective androgen receptor modulators (SARMS)

#298
20140213615
2014-07-31

Materials and Methods Useful to Induce Vacuolization, Cell Death, or a Combination Thereof

#299
20140178374
2014-06-26

BAX agonist, compositions, and methods related thereto

#300
20140171642
2014-06-19

Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors